cxc chemokine receptor 2 antagonist azd5069 vs durvalumab
| cxc chemokine receptor 2 antagonist azd5069 | durvalumab | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | CXC Chemokine Receptor 2 Antagonist AZD5069 | Durvalumab |
| cxc chemokine receptor 2 antagonist azd5069 | durvalumab | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | CXC Chemokine Receptor 2 Antagonist AZD5069 | Durvalumab |